Labeling of CC Chemokine Receptor 2 with a Versatile Intracellular Allosteric Probe.
Lisa S den HollanderBert L H BeerkensSebastian DekkersJacobus P D van VeldhovenNatalia V Ortiz ZacaríasCas van der HorstElisabeth G SiedersBert de ValkJianhui WangAdriaan P IJzermanLaura H HeitmanLaura H HeitmanPublished in: ACS chemical biology (2024)
Interest in affinity-based probes (AfBPs) as novel tools to interrogate G protein-coupled receptors (GPCRs) has gained traction in recent years. AfBPs represent an interesting and more versatile alternative to antibodies. In the present study, we report the development and validation of AfBPs that target the intracellular allosteric pocket of CCR2, a GPCR of interest for the development of therapies targeting autoimmune and inflammatory diseases and also cancer. Owing to the two-step labeling process of these CCR2 AfBPs through the incorporation of a click handle, we were successful in applying our most efficient probe in a variety of in vitro experiments and making use of multiple different detection techniques, such as SDS-PAGE and LC/MS-based proteomics. Collectively, this novel probe shows high selectivity, versatility, and applicability. Hence, this is a valuable alternative for CCR2-targeting antibodies and other traditional tool compounds and could aid in target validation and engagement in drug discovery.
Keyphrases
- living cells
- drug discovery
- small molecule
- dendritic cells
- regulatory t cells
- quantum dots
- fluorescent probe
- cancer therapy
- label free
- papillary thyroid
- reactive oxygen species
- single molecule
- multiple sclerosis
- social media
- immune response
- squamous cell carcinoma
- drug delivery
- loop mediated isothermal amplification
- real time pcr
- young adults